scholarly journals The Impact of Upper Face Botulinum Toxin Injections on Eyebrow Height and Forehead Lines

2019 ◽  
Vol 144 (3) ◽  
pp. 510e
Author(s):  
Zhen Zhai ◽  
Zuoliang Qi
Keyword(s):  
Botulinum Toxin ◽  
Upper Face ◽  
Botulinum Toxin Injections ◽  
The Impact

The Impact of Upper Face Botulinum Toxin Injections on Eyebrow Height and Forehead Lines

2018 ◽  
Vol 142 (5) ◽  
pp. 1212-1217 ◽  
Author(s):  
Samer F. Jabbour ◽  
Cyril J. Awaida ◽  
Joseph S. ElKhoury ◽  
Youssef A. Rayess ◽  
Rani B. Makhoul ◽  
...  
Keyword(s):  
Botulinum Toxin ◽  
Upper Face ◽  
Botulinum Toxin Injections ◽  
The Impact

The impact of long-term botulinum toxin injections on symptom severity in patients with spasmodic dysphonia

2004 ◽  
Vol 18 (3) ◽  
pp. 415-422 ◽  
Author(s):  
John F. Damrose ◽  
Stephen N. Goldman ◽  
Erik J. Groessl ◽  
Lisa A. Orloff
Keyword(s):  
Botulinum Toxin ◽  
Symptom Severity ◽  
Spasmodic Dysphonia ◽  
Botulinum Toxin Injections ◽  
The Impact

The Impact of Socioeconomic Status on Voice Outcomes in Patients With Spasmodic Dysphonia Treated With Botulinum Toxin Injections

2019 ◽  
Vol 128 (4) ◽  
pp. 316-322 ◽  
Author(s):  
Dianne Valenzuela ◽  
Joel Singer ◽  
Terry Lee ◽  
Amanda Hu
Keyword(s):  
Socioeconomic Status ◽  
Botulinum Toxin ◽  
Household Income ◽  
Spasmodic Dysphonia ◽  
Median Household Income ◽  
Botulinum Toxin Injections ◽  
The Impact ◽  
The Voice ◽  
Professional Voice ◽  
Validated Instrument

Objectives: To determine the impact of socioeconomic status (SES) on voice outcomes for spasmodic dysphonia (SD) patients treated with botulinum toxin injections. Methods: This was a prospective cross-sectional study in a tertiary care, academic voice clinic in Canada. Adult SD patients returning to the voice clinic for their botulinum toxin injections were recruited from October 2017 to April 2018. Patients completed a questionnaire on demographic data, the Hollingshead Four-Factor Index for socioeconomic status (validated instrument based on education, occupation, gender, and marital status), and the Voice-Handicap Index 10 (VHI-10) (validated instrument on self-reported vocal handicap). Primary outcome was the association between VHI-10 and Hollingshead Index. Secondary variables were median household income by postal code, duration of disease, gender, age, and professional voice user. Descriptive statistics and multiple linear regression were conducted. Results: One hundred and one patients (age = 62.8 ± 13.7 years, 20.8% male) were recruited with VHI-10 of 22.1 ± 8.1 (out of 40) and Hollingshead Index of 46.3 ± 11.7 (range, 8-66). Median household income was $75 875 ± $16 393, which was above the Canadian average of $70 336. About 91.1% were Caucasian, 54.4% had university degree, 86.1% spoke English, and 43.5% were employed. In multiple linear regression, there was mild to moderate negative correlation (r = −.292, P = .004) between VHI-10 and Hollingshead Index when controlling for disease duration, age, gender, and professional voice use. Conclusion: SD patients treated with botulinum toxin were mostly affluent, Caucasian, well educated, and English speakers. Lower self-perceived vocal handicap was associated with higher socioeconomic status.

Adaptive Changes in Locomotor Activity Following Botulinum Toxin Injection in Ankle Extensor Muscles of Cats

2002 ◽  
Vol 87 (1) ◽  
pp. 229-239 ◽  
Author(s):  
J. E. Misiaszek ◽  
K. G. Pearson
Keyword(s):  
Botulinum Toxin ◽  
Ankle Joint ◽  
Neural Control ◽  
Motor Behavior ◽  
Botulinum Toxin Injection ◽  
Medial Gastrocnemius ◽  
Functional Deficits ◽  
Extensor Muscles ◽  
Botulinum Toxin Injections ◽  
The Impact

The present study investigated the adaptations made in motor behavior following a temporary reduction in ankle extensor activity in the walking cat. Temporary muscle weakness was induced by injecting botulinum toxin into the lateral gastrocnemius (LG), plantaris (PL), and soleus (SOL) muscles, or SOL alone. The medial gastrocnemius (MG) muscle was not injected. Adaptations in the level of muscle activity were recorded using chronically implanted electromyographic (EMG) electrodes. Serial recordings were made prior to botulinum toxin injections and for several days following the injections. Kinematic analysis of ankle joint movements was made from video records to assess the impact of the botulinum toxin injections on the function of the ankle joint during walking. Following injection of the LG, PL, and SOL muscles with botulinum toxin, the amplitude of the MG burst increased over a period of a few days to a week. This increase was similar to the previously reported changes produced in MG following transection of the nerves serving LG, PL, and SOL. Following the weakening of the ankle extensor muscles, there was a temporary deficit in ankle function during walking as evidenced by a marked increase in the amount of ankle flexion that occurred at stance onset. This functional deficit recovered relatively quickly and was not associated with a return of the EMG pattern to the preinjection pattern. After recovery from the initial injections, a second injection of botulinum toxin into SOL alone was performed. No functional deficits were observed in the ankle movements during walking following this second injection. However, weakening SOL produced increases in the burst amplitudes of the MG, LG, and PL muscles over a period of a few days. This suggests that normal movements at the ankle during walking can be generated with more than one pattern of ankle extensor activity and that there is flexibility in how the necessary torque is produced. A final procedure, transection of the nerves serving LG, PL, and SOL, failed to produce any functional deficits in ankle movements. The implication is that adaptations to the neural control of ankle extensor activity that were induced by the initial procedure persisted after the recovery of the injected muscles and were sufficient to compensate for the subsequent challenges.

1710: Intra-Detrusor Botulinum Toxin Injections for Human Bladder Overactivity Decrease P2X3 but not PGP9.5 or Ache Expressing Suburothelial Innervation

2004 ◽  
Vol 171 (4S) ◽  
pp. 452-452 ◽  
Author(s):  
Apostolos Apostolidis ◽  
Roshni Popat ◽  
Yiangos Yiangou ◽  
Preston A. Baecker ◽  
Anthony Ford ◽  
...  
Keyword(s):  
Botulinum Toxin ◽  
Human Bladder ◽  
Botulinum Toxin Injections

Dry Needling Can Be An Alternative Treatment for Hemifacial Spasm

2020 ◽  
Vol 6 (2) ◽  
pp. 20-28
Author(s):  
Selly Marisdina ◽  
Henry Sugiharto ◽  
A Pradian
Keyword(s):  
Botulinum Toxin ◽  
Hemifacial Spasm ◽  
Alternative Treatment ◽  
Epidemiological Data ◽  
Clinical Severity ◽  
Decompression Surgery ◽  
Dry Needling ◽  
Significant Difference ◽  
Microvascular Decompression Surgery ◽  
Botulinum Toxin Injections

Back Ground: Hemifacial spasm is one of movement disorder case that commonly found in daily clinical practice. Epidemiological data are very limited, the average prevalence is 11 per 100,000 population, 14.5 per 100,000 in women and 7.4 per 100,000 in men. In Germany, the estimated prevalence is 8000 to 9000 peoples.1 The incidence of women is more than that of men with a ratio of 2:1. Based on Yaltho and Jankovic study in 2011, out of 215 patients, the ratio of men to women was 1:1.8.2 One study in Indonesia also reported that most of the subjects were female (64.7%).3 Treatment with botulinum toxin injections is preferred to microvascular decompression surgery therapy, but this injection is only effective in a few months and quite expensive. This study is the first study to assess the effectiveness of dry needling on clinical improvement of hemifacial spasm compared to standard therapy of botulinum toxin injection.Methods: The study design was quasi experimental. Total of 24 subjects were divided into two groups. The first group underwent dry needling intervention while the other had botulinum injection. Clinical severity before and after treatment in both groups was assessed using Jankovic and HFS7 scores.Results: In dry needling group there were significant differences between Jankovic and HFS7 score at baseline and at week 1, 2, 3 and 4. While in botox group significant differences were also Jankovic and HFS7 score at baseline and at weeks 2 and 4. There were also a significant difference of Jankovic and HFS7 score when we compared dry needling group to botulinum toxin group.Conclusion: Dry needling can be an alternative treatment for hemifacial spasm, although clinical improvements based on Jankovic and HFS7 scores in dry needling group were not as effective as those with botulinum toxin injections.

Sign in / Sign up

Export Citation Format

Share Document